Exela Technologies 6 00 Cum Convt Perptl Pref Shs Series B Stock Price, News & Analysis

Welcome to our dedicated page for Exela Technologies 6 00 Cum Convt Perptl Pref Shs Series B news (Ticker: XELAP), a resource for investors and traders seeking the latest updates and insights on Exela Technologies 6 00 Cum Convt Perptl Pref Shs Series B stock.

Exela Techs Inc 6% Series B (XELAP) is a preferred stock issued by Exela Technologies, Inc., a company that describes itself as a global business process automation and outsourcing specialist. The XELAP news stream on Stock Titan is closely tied to Exela’s corporate announcements, strategic initiatives, and capital markets updates, because developments at the issuer level can influence the risk profile of this preferred security.

Exela’s recent news highlights its activity across automation, data processing, and digital transformation. The company has reported strategic partnerships, such as its alliance between the Finance and Accounting Outsourcing business and recruitment firm Michael Page to expand Centers of Excellence and deploy Build‑Operate‑Transfer, captive, and Business Processes as a Service models. In healthcare, Exela has announced a strategic alliance with AIDEO Technologies to enhance its PCH Global platform with AI‑driven autonomous medical coding.

News items also cover cybersecurity and AI initiatives through the Reaktr business unit, including the launch of the SecAi service on Oracle Cloud Infrastructure and a sizable breach remediation contract described as accretive to Exela’s Information and Transaction Processing Solutions segment. These developments illustrate how Exela applies automation, AI, and cybersecurity capabilities across industries such as banking, healthcare, insurance, manufacturing, and the public sector.

For investors in XELAP, regulatory and capital markets news is particularly relevant. Exela has disclosed Nasdaq’s decision to delist its securities, the suspension of trading on Nasdaq, and the subsequent trading of its common and Series B preferred stock on the OTC Markets system. The company has also announced its intention to voluntarily delist from Nasdaq and pursue deregistration under the Exchange Act, subject to conditions and its right to delay or withdraw filings.

On this page, readers can follow earnings announcements, conference call notices, strategic partnerships, cybersecurity contracts, AI product launches, and listing‑status updates related to Exela. Monitoring these items helps investors understand the evolving context around Exela’s operations and capital structure, which are central to assessing the XELAP preferred stock. Bookmark this feed to review new company disclosures and historical news that frame the environment in which XELAP trades.